Condition: Advanced Esophageal Cancer
Interventions: Biological: Anti-MUC1 CAR-T cells; Biological: PD-1 knockout Engineered T cells; Combination Product: CAR-T combined with PD-1 Knockout T cells
Sponsors: The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Anjie Biomedical Technology Co;LTD
Recruiting
https://ift.tt/2RUNxxD
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου